The human Ig heavy chain variable region gene (VH) locus has been studied in considerable detail at the structural level; it contains -100-200 Ig heavy chain VH genes that have been grouped into six families (denoted VH1 through VH6) based on amino acid and nucleic acid sequence similarities (1-7) . The different families range in size from 1 member (VH6) to >25 members (VH3) and contain both functional genes and pseudogenes, interspersed over the entire 2,000-kb locus (2-4, 6).
The human Ig heavy chain variable region gene (VH) locus has been studied in considerable detail at the structural level; it contains -100-200 Ig heavy chain VH genes that have been grouped into six families (denoted VH1 through VH6) based on amino acid and nucleic acid sequence similarities (1) (2) (3) (4) (5) (6) (7) . The different families range in size from 1 member (VH6) to >25 members (VH3) and contain both functional genes and pseudogenes, interspersed over the entire 2,000-kb locus (2) (3) (4) 6) .
The contribution of different Ig heavy and light chain variable region gene segments to antibodies of particular specificity has been extensively characterized in murine systems (8) (9) (10) (11) (12) . In contrast to the murine system, little is known about VH gene utilization in different human B-lineage cell populations or in antibodies of particular specificity and function (reviewed in reference 13). To begin to characterize the contribution of human VH gene segments to antibody specificities, we have screened antibodies produced from a large panel of IgM-secreting, EBV transformed human B cell lines for VH gene utilization and antigen-binding pattern. The results show that there is no obvious correlation between antigen-binding pattern and expression of members of the families VH1VH5. In contrast, antibodies encoded by the VH6 gene family displayed binding patterns reminiscent of autoantibodies present in the sera of patients with SLE. Nucleotide sequence analysis revealed that both germline and somatically mutated VH6 genes are expressed in these antibodies and that the third complementarity-determining region (CDR3)t is conserved in length.
T cells as described previously (14) . EBV transformed cell lines were generated under limiting dilution conditions as described previously (15) .
ELISAs . Culture supernatants ofEBV transformed cell lines were screened for reactivity against a panel of25 antigens using direct binding ELISA assays . The panel ofantigens consisted ofBSA, dinitrophenol-BSA, trinitrophenol-BSA, arsonate-BSA, fluorescein-BSA, human IgG, human thyroglobulin, human insulin, ovalbumin, hen egg lysozyme (Hel), tetanus toxoid, rabies virus, cytochrome c (Cyt c), diptheria toxoid, native DNA (nDNA), single-stranded DNA (ssDNA), poly(dT) (PdT), poly(A:U), bovine heart cardiolipin (Card), RNA, smRNP, pooled pneumococcal polysaccharide (Pneumovax), al, 6 dextran and Haemophilus influenzae type b capsular polysaccharide . Controls, coating, and assay conditions were described elsewhere (14-17 ; and Logtenberg, T., manuscript submitted for publication) . Binding was confirmed in liquid phase inhibition ELISA as described elsewhere (18); immunopurified IgM or crude culture supernatant was preincubated with varying concentrations ofcompetitor and assayed for residual binding to solid-phase bound antigen . The concentration of competitor required for 50% inhibition reflects the relative avidity of the antibody for the competitor.
Northern Blotting. Total RNA from each cell line was separated on a I% agarose gel and analyzed by Northern blotting for hybridization to probes specific for each of the six known human VH gene families as described previously (6, 15) .
cDNA Cloning and Sequencing cDNA cloning and dideoxy sequencing were carried out as described (19, 20) with two modifications: (a) the starting material for cDNA synthesis was 50 t~g of total cellular RNA and (b) blunt-ended cDNAs were cloned into Bluescript (Stratagene, La Jolla, CA) . In each case both strands of cloned cDNA were sequenced .
Pblymerase Chain Reaction (PCR). DNA was amplified by using the Perkin-Elmer Cetus (Norwalk, CT) GeneAmp Kit using Taq 1 polymerase. 2 tug genomic DNA in polymerase buffer was mixed with appropriate primers (final concentration 1 pM) and subjected to 35 cycles of PCR, each consisting of 1 min of denaturation at 94°C, 2 min of cooling to 37°C and 3 min of extension at 72°C. After each cycle the extension time was increased by 5 s. After amplification, one-tenth ofthe reaction volume was subjected to electrophoresis on a 117c agarose gel, blotted to ZetaProbe membranes and probed with the 32 p-labeled VH6 probe . Primers used were TL20 5' TCCAAGTGGTATAATG 3, TL21 5' TCCAAGTGGAATACTA 3, TL22 5' TCTTGCACAGTAATACAC 3'. Antibodies from VH6-expressing Cell Lines Bind to DNA. Antigen binding properties of IgM molecules secreted by the 187 cell lines were assayed by screening culture supernatants in direct binding ELISA for reactivity against a panel of 24 antigens . A number of antibodies that used heavy chains containing VH segments from families 1-5 bound to particular antigens within the panel (Logtenberg, T, unpublished data); however, there was no obvious correlation between antigen-binding patterns and expression of these VH gene families (not shown) . In contrast, antibodies from each of the four VH6-expressing cell lines in the collection bound to ssDNA and PdT Binding to polynucleotides was not simply a matter of interaction with negatively charged molecules because no binding was observed to similarly charged molecules such as RNA and poly(A :U) (Table I, legend). Two of these clonal cell lines produced K light chains with variable regions from different Vu subgroups (Logtenberg, T, unpublished data) and the other two produced X light chains (Table I) . Therefore, the common binding activities were independent of the light chain used by the antibodies . The VH6 antibodies from individual clones also displayed various patterns of binding activities with a limited number of antigens in the panel, notably native DNA, cardiolipin, Cyt c and lysozyme. Such polyreactivity is a characteristic of some anti-DNA mAbs of both murine and human origin (reviewed in reference 21).
Germline and Somatically Mutated Vx6 Gene Segments in Anti-DNA Autoantibodies. The molecular basis of the observed similarities and differences in antigen binding patterns of antibodies secreted by .V146-expressing cell lines was investigated by analyzing cDNA clones of the Ig heavy chain mRNA expressed by each cell line .
Comparison of the nucleotide sequences of the VH6 genes expressed by fetal tissue-derived lines L16 and MLl to that of a germline VH6 segment (6-1G1 ; reference 6) revealed 100 To homology (Fig . 1 ) . An identical nucleotide sequence has been obtained from four additional germline VH6 segments from unrelated individuals, demonstrating that the human VH6 segment is highly conserved in the outbred human population (22, 23 ; and Logtenberg, T, unpublished) . The VH regions expressed by the adult peripheral blood lymphocyte-derived lines A10 and A431 differed from the prototypic germline sequence by three and six nucleotides, respectively (Fig. 1) . Eight of the nine differences were concentrated in the CDRI and CDR2 (antigen contact) regions of the VH segment, and in each case, resulted in amino acid replacements (Fig . 2) . The pattern and extent of nucleotide substitutions in the A10 and A431 VH6 genes suggested somatic mutations (24) . To confirm this possibility, we used the PCR to determine whether the "mutated" CDR2 sequence of cell line A431 existed in germline DNA from the same donor. PCR reactions used a common 3' primer (TL22) that represented sequences conserved in both germline and mutated VH6 genes and 
AGT GCT GCT TGG AAC TGG ATC AGG -----------------------CDR2> TGG CTG GGA ACC ACA TAG TAG AGG ------------------------

GAG TTC TCC CTG GAG CTG AAC TCT TAT TAG TGT GCA AGA GA -----------------------------------------------------------------
FR3> GTA TCT GTG AAA ACT CGA ATA ACC ATC AAC CCA GAC ACA TCC AAG AAC 90 GTG ACT CCC GAG GAG ACC GCT GTG either a 5' primer (TL20) specific for CDR3 of the germline VH6 gene or a 5' primer (TL21) specific for CDR3 of the "mutated" VH6 gene (Fig. 3) . With the 3' germline/5' germline primer combination, amplification from normal granulocyte DNA of the A431 donor generated a band of expected size (135 bp; Fig. 3 B, lane 1) that hybridized to the VH6 probe (Fig . 3 C, lane 1) ; but the 3' germline/5' mutated primer combination failed to generate a VH6 hybridizing band from this DNA (Fig.  3 , B and C, lanes 2). However, from A431 DNA the 3' germline/5' mutated combination primed amplification of the expected 135-bp VH-6 hybridizing band (Fig. 3 , B and C, lanes 3). Together, these data demonstrate that the mutated sequence exists
Nucleotide sequence of expressed VH6 genes. The nucleotide sequence of four VH6 cDNAs is compared with the sequence of apreviously published germline VH6 sequence (6-1G1). Dashes indicate nucleotide identity. in the DNA of the A431 line but not in normal granulocytes from the same donor. Therefore, the nucleotide sequence substitutions in cell line A431 (and most likely in A10) result from somatic mutations. The pattern and extent of replacements in the A431 and A10 VH regions suggest that these mutations were selected over multiple generations, characteristic of memory B cells (24, 25) . However, unlike memory B cells, A10 and A431 have undergone somatic mutation in the absence of isotype switching. Because T cells play an important role in directing switching, this observation might reflect absence of adequate T cell help for VH6-expressing B cells in healthy individuals . Also, it is notable that the A10 and A431 antibodies bind with high relative avidity to nDNA, a property not displayed by antibodies that express the germline VH6 segments; this property may reflect the mutations and/or contributions from the light chains in these antibodies (26) .
Conservation of CDR3 Length . All four of the characterized VHDHjH rearrangements contained short DH segments, ranging from 9-12 by in length (Fig. 4) . DH segments from L16 and A10 share extensive sequence homology with the DHQ52 germline sequence ; the DHQ52 is the most JH-proximal germline DH segment (27) and is used frequently in EBVtransformed human fetal liver pre-B cells (28) . The DH segments used in A431 and MLl rearrangements could not be unequivocally identified but also could have arisen from DHQ52 rearrangement and N-region insertions . The CDR3 regions in the four VH6 Ig heavy chains show extensive variation in amino acid sequence but are conserved in length in A10, L16, and MLl. The length of CDR3 of A431 differs by only one amino acid residue. Conservation of CDR3 length is not a property of human anti-DNA autoantibodies per se ; extensive variation in CDR3 length has been found in anti-DNA antibodies that use members of different VH families (29, 30) . However, conserved CDR3 length has been noted to be characteristic of certain rheumatoid factors of mice and man (31, 32) and of antibodies that predominate in some well-studied murine immune responses (reviewed in reference 33). Such constraints on heavy chain CDR3-length may reflect regulatory and/or functional (antigen-binding) aspects of antibodies (33, 34) .
Several features of the VH6 gene segment suggest a significant function for antibodies it encodes: (a) The germline VH6 gene segment is extremely well conserved at the nucleotide level in the human population; (6) The germline VH6 segment encodes polyreactive anti-DNA antibodies that also bind additional (auto)antigens ; (c) Somatically mutated VH6 genes are contained within autoantibodies that bind with high avidity to native DNA, a property of antibodies diagnostic for SLE (28) . (d) Based on conserved CDR3 length, VH6 antibodies may be highly selected . In addition, the VH6 gene family previously has been found to be unique in several ways : it has only one member (6) and that member is the most JH proximal of all known human VH segments (6, 22) . In this regard, the organization of Ig heavy chain VH genes influences their representation in primary antibody repertoires (reviewed in reference 35); for example, differentiating fetal murine pre-B cells preferentially rearrange and, as a result, express JH-proximal VH gene segments (36) . Similar to proximal murine VH gene segments, the VH6 gene appears to be preferentially expressed in fetal liver versus adult peripheral blood lymphocytes (Berman, J., and F Alt; manuscript in preparation) . Significantly, studies of murine antibodies that use JH-proximal VH genes demonstrated that a high proportion exhibit binding to self-antigens (37, 38) leading to the proposal that some such antibodies play a role in the early establishment of the murine B cell repertoire (38, 39) .
AGA GAA CTG GGG GAT GCT TTT GAT ATC TGG GGC CAA GGG ACA ATG GTC ACC GTC TCT TCA
TAA CTG GGGA The molecular genetic origin of pathogenic autoantibodies in patients with SLE is unknown ; they may derive from "natural" autoantibodies encoded by germline V genes present in every healthy individual (40, 41) or they may result from somatic mutations of V genes that encode other specificities (42) . The VH6-expressing B cells isolated in this study were not associated with autoimmune disease ; therefore, additional factors must be required for expansion and/or activation of B cells that secrete pathogenic autoantibodies . Because the VH6-encoded heavy chain appears to be the main contributor to the DNA-binding properties ofthe antibodies we tested, introduction of a functionally rearranged VH6 gene segment into transgenic mice may generate a population of B cells that express VH6-encoded autoantibodies. Such a mouse model may be useful in the study of factors that contribute to the generation of "autoagressive" antibodies and autoimmune disease .
Summary
Little is known about the utilization of human Ig heavy chain variable gene segments (VH segments) in different B-lineage cell populations or in antibodies of particular specificity and function. We now demonstrate that human antibodies with Ig VH regions encoded by the most JH-proximal human VH segment (VH6) have specificities resembling those of autoantibodies present in sera of patients with systemic lupus erythematosus (e.g., anti-DNA and anticardiolipin) . These specificities appear to be encoded by the germline VH6 gene because the activity was found in multiple independent VH6 antibodies in which the light chain varied with respect to isotype and Vrc subgroup. Features of CDR3 length and somatic mutation patterns in several VH6 antibodies suggested that they were selected by the immune system. We thank T. Keith Blackwell and George Yancopoulos, Gary Rathbun, and Jeffrey Berman for critically reading this manuscript .
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